R

Revolution Medicines Tech Stack

Oncology drug developer focused on RAS-driven cancers

Biotechnology Research Redwood City, California 501–1,000 employees Founded 2014 Public Company

Revolution Medicines is a public biotech company developing targeted therapies for RAS-addicted cancers, which represent roughly 30% of new cancer diagnoses. The hiring and tech-stack mix reveals a clinical-stage organization: adopting Snakemake and Nextflow for bioinformatics workflows while maintaining legacy pharmacokinetic tools (NONMEM, WinNonlin), paired with heavy investment in regulatory and clinical operations roles. Active projects span clinical study execution, regulatory submissions, and CMC strategy—typical of companies navigating the drug development gauntlet toward launch readiness.

Tech Stack 59 technologies

Core StackPython AWS Linux SAS Workday AutoCAD ServiceNow Java NONMEM R Seurat Scanpy Azure DNAnexus WinNonlin HPLC UPLC Excel PowerPoint Word Visio Git GATK Bioconductor CDISC Veeva Vault RIM ADP Workforce Now Electronic Data Capture Veeva Quality Vault Bash+26 more

AdoptingSnakemake Nextflow CDISC

What Revolution Medicines Is Building

◆Challenges

Ensuring compliance with global pharmacovigilance regulations
Ensuring timely access to oncolytics
Launch readiness
Reimbursement process challenges
Meeting regulatory submission timelines
Cross-functional coordination
Removing barriers to care
Maintaining inspection readiness
Inventory management
Delivering compliant clinical supply on time

▲Active Projects

Clinical study execution
Sop development and training
Jca dossier development
Regulatory submission support
Global cmc regulatory strategy development
Integrated evidence plan (iep) development
Simulation studies
Trade compliance policy development
Data standardization
Regulatory document submissions

Hiring Activity

Steady330 roles · 140 in 30d

Department

Sales

70

Research

65

Healthcare

51

Ops

25

Legal

20

Data

19

Marketing

13

Regulatory

11

Seniority

Senior

149

Director

106

Intern

22

VP

14

Manager

13

Mid

11

Principal

4

Junior

3

Notable leadership hires: Associate Director, Clinical Operations, Franchise Head, Forecasting Director, Commercial Lead, Medical Director

Company intelligence

Find more companies like Revolution Medicines by tech stack, pain points and active projects

Get started free

About Revolution Medicines

Revolution Medicines discovers and develops targeted oncology medicines, with current focus on RAS-addicted cancers. Based in Redwood City, the company operates across discovery, development, regulatory, and commercial functions across the US, Germany, Japan, Switzerland, and France. The organization spans research, clinical operations, healthcare, regulatory, and data functions. Active project work centers on clinical trial execution, regulatory dossier preparation, pharmacovigilance compliance, and commercial launch planning—indicating mid-to-late stage development programs navigating toward market authorization.

HeadquartersRedwood City, California

Company Size501–1,000 employees

Founded2014

Hiring MarketsUnited States, Germany, Japan, Switzerland, France

Frequently Asked Questions

What is Revolution Medicines working on?

Clinical study execution, regulatory submissions, CMC strategy, integrated evidence plans, pharmacovigilance compliance, and launch readiness across RAS-driven cancer programs.

What bioinformatics tools does Revolution Medicines use?

Stack includes GATK, Bioconductor, Scanpy, Seurat, and R for genomics; adopting Snakemake and Nextflow for workflow automation. NONMEM, WinNonlin, and SAS for pharmacokinetic modeling.